PEPSCAN Therapeutics focuses on peptide & protein mimicry technology for the generation of molecular therapeutics, in particular monoclonal antibodies and therapeutic peptides. Pepscan's proprietary CLIPSTM technology, which allows structural fixation of linear peptides, provides a versatile tool to mimic protein binding sites by stabilizing peptides in the biologically relevant conformation.  Synthetic CLIPSTM immunogens, mimicking the biologically relevant parts of target GPCR's, have proven highly successful in yielding functional antibodies.  Pepscan's technologies have shown to improve the activity and stability of existing or candidate peptide drugs, and thus provide great opportunities for new therapeutic peptide drugs.  

Web: www.pepscan.com